Global Adalimumab Biosimilar Market: Innovations and Opportunities

added blog Health

2025-02-18 12:09:01

Adalimumab, originally marketed under the brand name Humira, is one of the most widely prescribed biologic drugs for the treatment of autoimmune diseases like rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. With Humira approaching its patent expiry in recent years, the Adalimumab biosimilars market has emerged as a significant opportunity for both pharmaceutical...

0 Komen 0 Perkongsian 748 Views 0 review